A serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T-LYMPHOCYTES and MACROPHAGES. It is seen predominantly in children with systemic onset JUVENILE IDIOPATHIC ARTHRITIS.
Arthritis of children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.
The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants.
A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.
A characteristic symptom complex.
Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types.
The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.)
Leukopenia is a condition characterized by an abnormally low white blood cell count (less than 4,000 cells per microliter of blood) in peripheral blood, increasing the risk of infection due to decreased immune defense.
Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.
A subnormal level of BLOOD PLATELETS.
The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest.
An abnormal elevation of body temperature, usually as a result of a pathologic process.
Mononuclear phagocytes derived from bone marrow precursors but resident in the peritoneum.

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. (1/19)

 (+info)

Systemic JIA: new developments in the understanding of the pathophysiology and therapy. (2/19)

 (+info)

Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. (3/19)

 (+info)

Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. (4/19)

 (+info)

Macrophage activation syndrome in autoimmune disease. (5/19)

 (+info)

Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. (6/19)

 (+info)

Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. (7/19)

 (+info)

[Case of systemic-onset juvenile idiopathic arthritis complicated with sepsis --usefulness of cytokine profile for the differentiation between macrophage activation syndrome and sepsis]. (8/19)

The differential diagnosis of macrophage activation syndrome (MAS) and sepsis must be considered in the clinical course of systemic-onset juvenile idiopathic arthritis (s-JIA) with sudden onset of high-grade fever and abnormal laboratory findings, including leukocytopenia, thrombocytopenia, and coagulopathy. In this report, we describe the case of a 17-month-old girl diagnosed with s-JIA complicated with sepsis. Her serum interleukin (IL)-18 level was significantly elevated throughout the clinical course. Furthermore, compared to other MAS patients, she showed a significantly elevated serum IL-6 level and procalcitonin in sepsis. Therefore, our results suggest that a patient's cytokine profile may be a useful indicator of disease activity and may thus help in the differential diagnosis of sepsis and MAS in s-JIA.  (+info)

Macrophage Activation Syndrome (MAS) is a severe, life-threatening complication of certain inflammatory diseases, including rheumatic diseases such as systemic juvenile idiopathic arthritis (sJIA), adult-onset Still's disease (AOSD), and catastrophic antiphospholipid syndrome (CAPS). It is also known as hemophagocytic lymphohistiocytosis (HLH) or secondary HLH.

MAS is characterized by the uncontrolled activation and proliferation of macrophages, which are large white blood cells that play a crucial role in the immune system by engulfing and destroying foreign substances, microbes, and cancer cells. In MAS, these activated macrophages release high levels of inflammatory cytokines, leading to a hyperinflammatory state that can damage multiple organs, including the liver, spleen, kidneys, and central nervous system.

The symptoms of MAS include fever, fatigue, rash, lymphadenopathy (swollen lymph nodes), hepatosplenomegaly (enlarged liver and spleen), coagulopathy (bleeding disorders), and cytopenias (low blood cell counts). The diagnosis of MAS is based on clinical criteria, laboratory tests, and bone marrow aspiration findings. Treatment typically involves high-dose corticosteroids, immunosuppressive agents, and targeted therapies that modulate the immune system. In severe cases, stem cell transplantation may be necessary.

Juvenile arthritis (JA) is a term used to describe a group of autoimmune and inflammatory disorders that can affect children aged 16 or younger. In JA, the immune system mistakenly attacks the body's own tissues, causing inflammation in the joints, which can lead to pain, swelling, stiffness, and damage over time.

There are several types of juvenile arthritis, including:

1. Juvenile Idiopathic Arthritis (JIA): This is the most common form of JA, and it includes several subtypes that are classified based on the number of joints affected and the presence or absence of certain symptoms.
2. Juvenile Systemic Lupus Erythematosus (JSLE): This is a type of lupus that affects children, and it can cause inflammation in various parts of the body, including the joints, skin, kidneys, and lungs.
3. Juvenile Dermatomyositis (JDM): This is a rare autoimmune disorder that causes inflammation of the blood vessels, leading to muscle weakness, skin rashes, and joint pain.
4. Juvenile Scleroderma: This is a group of disorders that cause hardening and tightening of the skin and connective tissues, which can also affect the joints.
5. Juvenile Psoriatic Arthritis (JPsA): This is a type of arthritis that affects children who have psoriasis, a chronic skin condition. JPsA can cause inflammation in the joints and skin.

The causes of juvenile arthritis are not fully understood, but it is believed to involve a combination of genetic and environmental factors. There is no cure for JA, but treatments such as medication, physical therapy, and lifestyle changes can help manage the symptoms and prevent long-term complications.

Macrophage activation is a process in which these immune cells become increasingly active and responsive to various stimuli, such as pathogens or inflammatory signals. This activation triggers a series of changes within the macrophages, allowing them to perform important functions like phagocytosis (ingesting and destroying foreign particles or microorganisms), antigen presentation (presenting microbial fragments to T-cells to stimulate an immune response), and production of cytokines and chemokines (signaling molecules that help coordinate the immune response).

There are two main types of macrophage activation: classical (or M1) activation and alternative (or M2) activation. Classical activation is typically induced by interferon-gamma (IFN-γ) and lipopolysaccharide (LPS), leading to a proinflammatory response, enhanced microbicidal activity, and the production of reactive oxygen and nitrogen species. Alternative activation, on the other hand, is triggered by cytokines like interleukin-4 (IL-4) and IL-13, resulting in an anti-inflammatory response, tissue repair, and the promotion of wound healing.

It's important to note that macrophage activation plays a crucial role in various physiological and pathological processes, including immune defense, inflammation, tissue remodeling, and even cancer progression. Dysregulation of macrophage activation has been implicated in several diseases, such as autoimmune disorders, chronic infections, and cancer.

Hemophagocytic Lymphohistiocytosis (HLH) is a rare and serious condition characterized by an uncontrolled immune response leading to inflammation and damage in various organs of the body. It occurs when certain immune cells, including lymphocytes and histiocytes (a type of white blood cell), become overactive and start to destroy other blood cells, particularly red blood cells and platelets. This results in symptoms such as fever, enlarged liver and spleen, cytopenia (decreased number of blood cells), and increased levels of inflammatory markers in the body.

HLH can be primary or secondary. Primary HLH is an inherited disorder caused by genetic mutations that affect the immune system's regulation. Secondary HLH, on the other hand, is acquired due to factors such as infections, malignancies, or autoimmune diseases. Treatment for HLH typically involves a combination of chemotherapy, immunosuppressive drugs, and sometimes bone marrow transplantation. Early diagnosis and treatment are crucial for improving outcomes in patients with this condition.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Ferritin is a protein in iron-metabolizing cells that stores iron in a water-soluble form. It is found inside the cells (intracellular) and is released into the bloodstream when the cells break down or die. Measuring the level of ferritin in the blood can help determine the amount of iron stored in the body. High levels of ferritin may indicate hemochromatosis, inflammation, liver disease, or other conditions. Low levels of ferritin may indicate anemia, iron deficiency, or other conditions.

Macrophages are a type of white blood cell that are an essential part of the immune system. They are large, specialized cells that engulf and destroy foreign substances, such as bacteria, viruses, parasites, and fungi, as well as damaged or dead cells. Macrophages are found throughout the body, including in the bloodstream, lymph nodes, spleen, liver, lungs, and connective tissues. They play a critical role in inflammation, immune response, and tissue repair and remodeling.

Macrophages originate from monocytes, which are a type of white blood cell produced in the bone marrow. When monocytes enter the tissues, they differentiate into macrophages, which have a larger size and more specialized functions than monocytes. Macrophages can change their shape and move through tissues to reach sites of infection or injury. They also produce cytokines, chemokines, and other signaling molecules that help coordinate the immune response and recruit other immune cells to the site of infection or injury.

Macrophages have a variety of surface receptors that allow them to recognize and respond to different types of foreign substances and signals from other cells. They can engulf and digest foreign particles, bacteria, and viruses through a process called phagocytosis. Macrophages also play a role in presenting antigens to T cells, which are another type of immune cell that helps coordinate the immune response.

Overall, macrophages are crucial for maintaining tissue homeostasis, defending against infection, and promoting wound healing and tissue repair. Dysregulation of macrophage function has been implicated in a variety of diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions.

Leukopenia is a medical term used to describe an abnormally low white blood cell (WBC) count in the blood. White blood cells are crucial components of the body's immune system, helping to fight infections and diseases. A normal WBC count ranges from 4,500 to 11,000 cells per microliter (μL) of blood in most laboratories. Leukopenia is typically diagnosed when the WBC count falls below 4,500 cells/μL.

There are several types of white blood cells, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Neutropenia, a specific type of leukopenia, refers to an abnormally low neutrophil count (less than 1,500 cells/μL). Neutropenia increases the risk of bacterial and fungal infections since neutrophils play a significant role in combating these types of pathogens.

Leukopenia can result from various factors, such as viral infections, certain medications (like chemotherapy or radiation therapy), bone marrow disorders, autoimmune diseases, or congenital conditions affecting white blood cell production. It is essential to identify the underlying cause of leukopenia to provide appropriate treatment and prevent complications.

Antigens are substances (usually proteins) on the surface of cells, or viruses, bacteria, and other microorganisms, that can stimulate an immune response.

Differentiation in the context of myelomonocytic cells refers to the process by which these cells mature and develop into specific types of immune cells, such as monocytes, macrophages, and neutrophils.

Myelomonocytic cells are a type of white blood cell that originate from stem cells in the bone marrow. They give rise to two main types of immune cells: monocytes and granulocytes (which include neutrophils, eosinophils, and basophils).

Therefore, 'Antigens, Differentiation, Myelomonocytic' refers to the study or examination of how antigens affect the differentiation process of myelomonocytic cells into specific types of immune cells. This is an important area of research in immunology and hematology as it relates to understanding how the body responds to infections, inflammation, and cancer.

Thrombocytopenia is a medical condition characterized by an abnormally low platelet count (thrombocytes) in the blood. Platelets are small cell fragments that play a crucial role in blood clotting, helping to stop bleeding when a blood vessel is damaged. A healthy adult typically has a platelet count between 150,000 and 450,000 platelets per microliter of blood. Thrombocytopenia is usually diagnosed when the platelet count falls below 150,000 platelets/µL.

Thrombocytopenia can be classified into three main categories based on its underlying cause:

1. Immune thrombocytopenia (ITP): An autoimmune disorder where the immune system mistakenly attacks and destroys its own platelets, leading to a decreased platelet count. ITP can be further divided into primary or secondary forms, depending on whether it occurs alone or as a result of another medical condition or medication.
2. Decreased production: Thrombocytopenia can occur when there is insufficient production of platelets in the bone marrow due to various causes, such as viral infections, chemotherapy, radiation therapy, leukemia, aplastic anemia, or vitamin B12 or folate deficiency.
3. Increased destruction or consumption: Thrombocytopenia can also result from increased platelet destruction or consumption due to conditions like disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), or severe bacterial infections.

Symptoms of thrombocytopenia may include easy bruising, prolonged bleeding from cuts, spontaneous nosebleeds, bleeding gums, blood in urine or stools, and skin rashes like petechiae (small red or purple spots) or purpura (larger patches). The severity of symptoms can vary depending on the degree of thrombocytopenia and the presence of any underlying conditions. Treatment for thrombocytopenia depends on the cause and may include medications, transfusions, or addressing the underlying condition.

I'm sorry for any confusion, but "International Cooperation" is not a medical term. It refers to the collaboration and exchange of resources and information between countries or international organizations in various fields, including politics, economics, culture, environment, and security, among others. In the context of healthcare and medicine, international cooperation can involve joint research projects, sharing of data and clinical trial results, collaborative efforts to combat global health issues (such as infectious diseases or chronic conditions), capacity building in low-resource settings, and standardizing medical practices and guidelines across countries.

Fever, also known as pyrexia or febrile response, is a common medical sign characterized by an elevation in core body temperature above the normal range of 36.5-37.5°C (97.7-99.5°F) due to a dysregulation of the body's thermoregulatory system. It is often a response to an infection, inflammation, or other underlying medical conditions, and it serves as a part of the immune system's effort to combat the invading pathogens or to repair damaged tissues.

Fevers can be classified based on their magnitude:

* Low-grade fever: 37.5-38°C (99.5-100.4°F)
* Moderate fever: 38-39°C (100.4-102.2°F)
* High-grade or severe fever: above 39°C (102.2°F)

It is important to note that a single elevated temperature reading does not necessarily indicate the presence of a fever, as body temperature can fluctuate throughout the day and can be influenced by various factors such as physical activity, environmental conditions, and the menstrual cycle in females. The diagnosis of fever typically requires the confirmation of an elevated core body temperature on at least two occasions or a consistently high temperature over a period of time.

While fevers are generally considered beneficial in fighting off infections and promoting recovery, extremely high temperatures or prolonged febrile states may necessitate medical intervention to prevent potential complications such as dehydration, seizures, or damage to vital organs.

Peritoneal macrophages are a type of immune cell that are present in the peritoneal cavity, which is the space within the abdomen that contains the liver, spleen, stomach, and intestines. These macrophages play a crucial role in the body's defense against infection and injury by engulfing and destroying foreign substances such as bacteria, viruses, and other microorganisms.

Macrophages are large phagocytic cells that originate from monocytes, which are a type of white blood cell produced in the bone marrow. When monocytes enter tissue, they can differentiate into macrophages, which have a variety of functions depending on their location and activation state.

Peritoneal macrophages are involved in various physiological processes, including the regulation of inflammation, tissue repair, and the breakdown of foreign substances. They also play a role in the development and progression of certain diseases, such as cancer and autoimmune disorders.

These macrophages can be collected from animals or humans for research purposes by injecting a solution into the peritoneal cavity and then withdrawing the fluid, which contains the macrophages. These cells can then be studied in vitro to better understand their functions and potential therapeutic targets.

Macrophage activation syndrome is a severe, potentially life-threatening, complication of several chronic rheumatic diseases of ... There is uncontrolled activation and proliferation of macrophages, and T lymphocytes, with a marked increase in circulating ... A febrile patient with known or suspected SoJIA must be considered for macrophage activation if: Ferritin >684 ng/ml and any 2 ...
Macrophage activation syndrome is characterized by pancytopenia, liver insufficiency,... ... Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic disease that, for unknown reasons, occurs ... encoded search term (Macrophage Activation Syndrome) and Macrophage Activation Syndrome What to Read Next on Medscape ... Differential diagnosis between macrophage activation syndrome and a lupus flare or between macrophage activation syndrome and ...
Macrophage activation syndrome is characterized by pancytopenia, liver insufficiency,... ... Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic disease that, for unknown reasons, occurs ... encoded search term (Macrophage Activation Syndrome) and Macrophage Activation Syndrome What to Read Next on Medscape ... Differential diagnosis between macrophage activation syndrome and a lupus flare or between macrophage activation syndrome and ...
NLRC4 have been associated with a potentially life-threatening autoinflammatory disorder called macrophage activation syndrome ... However, continual activation of this process can lead to serious diseases like MAS. Identifying mutations in this gene helps ... MAS). The mutations cause aggregation and continual activation of a cellular sensor (shown in red in the image) that triggers ...
BACKGROUND Macrophage activation syndrome (MAS) is a life-threatening complication of Stills disease (SD) characterized by ... overt immune cell activation and cytokine storm. We aimed to further understand the immunologic landscape of SD and MAS.METHOD ...
... inflammatory disorders that is thought to be caused by excessive activation and proliferation of T lymphocytes and macrophages ... Macrophage activation syndrome (MAS) is a serious complication of childhood systemic ... Macrophage activation syndrome: A diagnostic challenge (Review). Bojan A, Parvu A, Zsoldos IA, Torok T, Farcas AD. Bojan A, et ... Macrophage activation syndrome in juvenile idiopathic arthritis. Cortis E, Insalaco A. Cortis E, et al. Acta Paediatr Suppl. ...
Find symptoms and other information about Macrophage activation syndrome. ... A rare hemophagocytic syndrome characterized by excessive activation and proliferation of macrophages and T cells occurring in ... A rare hemophagocytic syndrome characterized by excessive activation and proliferation of macrophages and T cells occurring in ... About Macrophage activation syndrome. Many rare diseases have limited information. Currently GARD aims to provide the following ...
... macrophage activation syndrome (MAS) is a term used by rheumatologists to describe a potentially life-threatening complication ... The Immunology of Macrophage Activation Syndrome Courtney B Crayne 1 , Sabrin Albeituni 2 , Kim E Nichols 2 , Randy Q Cron 1 ... The Immunology of Macrophage Activation Syndrome Courtney B Crayne et al. Front Immunol. 2019. . ... Connective tissue disease with macrophage activation syndrome: A case report. Chen Q, Zhang Q, Wang X. Chen Q, et al. Medicine ...
Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12:259-68. DOIPubMedGoogle Scholar ... Macrophage activation syndrome-associated markers in severe dengue. Int J Med Sci. 2016;13:179-86. DOIPubMedGoogle Scholar ... 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European ... macrophage activation syndrome; NK, natural killer; sIL-2R, soluble interleukin 2 receptor; -, feature not included in disease ...
Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases (i.e SLE, Juvenile idiopathic ... Lerkvaleekul B, Vilaiyuk S. Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol. 2018;10:117-128. ... It manifests as uncontrolled activation and proliferation of T lymphocytes and macrophages ...
5.5 Macrophage Activation Syndrome. Macrophage activation syndrome (MAS) (hemophagocytic lymphohistiocytosis) is a known, life- ... 5.5 Macrophage Activation Syndrome 5.6 Embryo-Fetal Toxicity 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 6.2 ... Macrophage Activation Syndrome: Monitor for and treat promptly; discontinue PURIXAN. (5.5). * Embryo-Fetal Toxicity: Can cause ... Mercaptopurine is a purine analog that undergoes intracellular transport and activation to form metabolites including ...
Background/Purpose: Macrophage activation syndrome (MAS) constitutes over 5% of multi-organ dysfunction syndrome in adults, ... Abstracts tagged "macrophage activation syndrome and multiorgan failure". *. Abstract Number: 3082 • 2016 ACR/ARHP Annual ... Macrophage Activation Syndrome Is Identified By Coagulopathy, Hyperferritinemia, Fever, and Cytopenia in Hospitalized Patients ...
IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage ... target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome ...
5.4 Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome. Hemophagocytic Lymphohistiocytosis/Macrophage Activation ... 5.4 Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome 5.5 Hypersensitivity Reactions 5.6 Severe Infections 5.7 ... Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome [see Warnings and Precautions (5.4)] *Hypersensitivity ... Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: Administer treatment per institutional standards. (5.4). * ...
Return to Article Details Kikuchi Fujimoto disease with macrophage activation syndrome, seizures, and pleuritis in a young ...
... low-dose etoposide in patients with refractory macrophage activation syndrome (MAS) associated with adu... ... Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome. Pediatric rheumatology online journal ... Macrophage activation syndrome (MAS) is a life-threatening complication that occurs in 10-19% of patients with AOSD (hereafter ... Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med 2015;66:145-159. ...
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome. *Hemophagocytic lymphohistiocytosis/macrophage activation ... Hemophagocytic lymphohistiocytosis (HLH)/macrophage activation syndrome (MAS) reported: it is a potentially life-threatening ... within 12 hr of first-line interventions or development of hemophagocytic lymphohistiocytosis/macrophage activation syndrome ... Cytokine release syndrome. *Cytokine release syndrome (CRS), including fatal or life-threatening reactions, occurred following ...
... dealing with diseases like macrophage activation syndrome. He also has a special interest in uveitis, or eype inflammation of ...
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome? Ombrello MJ, Schulert GS ... Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Stills disease. Nagai H, ...
Macrophage activation syndrome, a severe illness that may develop with systemic JIA ... Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic ...
Macrophage activation syndrome, a severe illness that may develop with systemic JIA ... Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic ...
Clinical features of macrophage activation syndrome in the adult northern Chinese population.. Li X; Qu B; Nie Y; Zhu G; Li W; ... Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the ... Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.. Lin CI; Yu HH; Lee JH; ... Macrophage Activation Syndrome.. Sen ES; Clarke SL; Ramanan AV. Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031. ...
Macrophage Activation Syndrome Macrophage activation syndrome is hemophagocytic lymphohistiocytosis Hemophagocytic ... In 7 to 10% of patients, systemic JIA may be complicated by macrophage activation syndrome Macrophage Activation Syndrome ... Macrophage activation syndrome is a severe, overwhelming, and life-threatening cytokine storm syndrome caused by an ... Macrophage activation syndrome may respond well to successful treatment of the underlying rheumatic disease. Specific treatment ...
... is a potentially life-threatening hyperinflammatory syndrome that occurs after primary SARS-Co ... and macrophage activation syndrome (MAS) is unknown.. Methods: We studied a prospective cohort of nineteen MIS-C and nine KD ... Suggest Overlap between Kawasaki Disease and Macrophage Activation Syndrome. 31 Pages Posted: 22 Feb 2021 ... Background: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening hyperinflammatory syndrome ...
Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002;14:548-552. ... Macrophage activation in these disorders may be attributed to dysregulation of cytokines such as IL-1, IL-6, IFN-y and TNF-a. ... The answer is e, hemophagocytic syndrome. The bone marrow aspirate shown demonstrates macrophage hemophagocytosis of non- ... nucleated red blood cells, consistent with hemophagocytic syndrome (HPS). The hemophagocytic syndromes may be classified as ...
Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol 2016; 12(5):259-268. doi:10.1038/nrrheum. ... The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. ... as well as secondary forms such as macrophage activation syndrome (MAS) and secondary HLH, which are often encountered in the ... sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal ...
Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS), including fatal and life-threatening reactions, ... Hemophagocytic Lymphohistiocytosis (HLH)/Macrophage Activation Syndrome (MAS): Fatal HLH occurred in one patient (1%), 99 days ... Guillain-Barré Syndrome: A fatal outcome following Guillain-Barré Syndrome (GBS) has occurred in another ongoing study of ... Cytokine Release Syndrome (CRS), including fatal or life-threatening reactions, occurred in patients following treatment with ...
Cytokine release syndrome (CRS). Neurologic toxicities. Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/ ... Guillain-Barré syndrome, peripheral neuropathies, cranial nerve palsies. Monitor for neurologic toxicities for 4 weeks after ... Risk of neurologic toxicities including immune effector cell-associated neurotoxicity syndrome, parkinsonism, ...
... and macrophage-activation syndrome. While one approach to improve engineered T cell therapies involves identifying antigens or ... Achieving the goals of this FOA should establish a deeper understanding of the origins and activation pathways leading to ... Additional toxicities associated with adoptive T-cell therapies include cytokine-release syndrome, neurotoxicity, ... lymphocyte-activation gene 3 (LAG-3), T cell immunoglobulin mucin 3 (TIM-3), VISTA, and CD47 as well as immune-activating ...
Recurrent macrophage activation syndrome (MAS) is very rare. We present the case of an adolescent boy with human leukocyte ... Recurrent macrophage activation syndrome since toddler age in an adolescent boy with HLA B27 positive juvenile ankylosing ...

No FAQ available that match "macrophage activation syndrome"

No images available that match "macrophage activation syndrome"